News - Jabez Biosciences

For Patients: Our Phase I trial is currently enrolling!

News & Media Center

Latest Press Releases

Multi-institutional team awarded NCI grant to open novel AML trial

June 23, 2025

Media Coverage & Appearances

Multi-institutional team awarded NCI grant to open novel AML trial

Jabez Biosciences, Inc. Announced Phase 1 Clinical Trial of JBZ-001 at AACR 2025

Jabez Biosciences, Inc. Announces First Patient Dosed in Phase 1 Oncology Clinical Study of JBZ-001

Check us out on Social Media